71 related articles for article (PubMed ID: 22108340)
1. Faecal calprotectin in HIV-infected, HAART-naïve Ugandan children.
Hestvik E; Olafsdottir E; Tylleskar T; Aksnes L; Kaddu-Mulindwa D; Ndeezi G; Tumwine JK; Grahnquist L
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):785-90. PubMed ID: 22108340
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
[TBL] [Abstract][Full Text] [Related]
3. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey.
Hestvik E; Tumwine JK; Tylleskar T; Grahnquist L; Ndeezi G; Kaddu-Mulindwa DH; Aksnes L; Olafsdottir E
BMC Pediatr; 2011 Feb; 11():9. PubMed ID: 21284894
[TBL] [Abstract][Full Text] [Related]
5. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
6. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis.
Sýkora J; Siala K; Huml M; Varvařovská J; Schwarz J; Pomahačová R
Acta Paediatr; 2010 Sep; 99(9):1389-95. PubMed ID: 20412103
[TBL] [Abstract][Full Text] [Related]
8. Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure.
Frange P; Briand N; Avettand-fenoel V; Veber F; Moshous D; Mahlaoui N; Rouzioux C; Blanche S; Chaix ML
Pediatr Infect Dis J; 2011 Aug; 30(8):684-8. PubMed ID: 21427626
[TBL] [Abstract][Full Text] [Related]
9. CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART).
Böhler T; Wintergerst U; Linde R; Belohradsky BH; Debatin KM
Pediatr Res; 2001 Jan; 49(1):101-10. PubMed ID: 11134499
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Helicobacter pylori in HIV-infected, HAART-naïve Ugandan children: a hospital-based survey.
Hestvik E; Tylleskar T; Ndeezi G; Grahnquist L; Olafsdottir E; Tumwine JK; Kaddu-Mulindwa DH
J Int AIDS Soc; 2011 Jun; 14():34. PubMed ID: 21714943
[TBL] [Abstract][Full Text] [Related]
11. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
13. Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children.
Fortuny C; Noguera-Julian A; Alsina L; Bellido R; Sánchez E; Muñoz-Almagro C; Ruiz L; Jiménez R
Pediatr Infect Dis J; 2011 May; 30(5):435-8. PubMed ID: 21030884
[TBL] [Abstract][Full Text] [Related]
14. The reference range of CD4+ and CD8+ T-lymphocytes in healthy non-infected infants born to HIV-1 seropositive mothers; a preliminary study at Siriraj Hospital.
Likanonsakul S; Wasi C; Thepthai C; Sutthent R; Louisirirotchanakul S; Chearskul S; Vanprapa N; Lebnark T
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):453-63. PubMed ID: 10437939
[TBL] [Abstract][Full Text] [Related]
15. Impact on weight and height with the use of HAART in HIV-infected children.
Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
18. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
Newell ML; Patel D; Goetghebuer T; Thorne C;
J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
[TBL] [Abstract][Full Text] [Related]
19. First-line antiretroviral treatment of HIV-infected children. A choice largely based on adult data.
Prescrire Int; 2011 Apr; 20(115):101-4. PubMed ID: 21648216
[TBL] [Abstract][Full Text] [Related]
20. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
